Abstract
Tuberculosis (TB) remains a significant public health problem in developing countries, but its diagnosis can be challenging as it may mimic malignancy or other granulomatous diseases. Although pulmonary TB is the most common form, TB can spread hematogenously, lymphatically, or by direct extension to any tissue or organ. We report a 62-year-old female who underwent 18F-fluorodeoxyglucose positron emission tomography/computed tomography (18F-FDG PET/CT) for malignancy evaluation, was diagnosed with extrapulmonary TB, and had her treatment response assessed with 18F-FDG PET/CT.
Keywords:
Tuberculosis, malignancy, FDG PET, extrapulmonary, PET/CT
Ethics
Informed Consent: Informed consent was obtained from the patient for publication.
Authorship Contributions
Concept: R.L.U.B., H.B.S., Design: R.L.U.B., H.B.S., Data Collection or Processing: C.G., Literature Search: C.G., Writing: C.G., R.L.U.B., H.B.S.
Conflict of Interest: No conflicts of interest were declared by the authors.
Financial Disclosure: The authors declare that this study has received no financial support.
References
1
Wang X, Shi X, Yi C, Chen Z, Zhang B, Zhang X. Hepatic tuberculosis mimics metastasis revealed by 18F-FDG PET/CT. Clin Nucl Med. 2014;39:e325-e327.
2
Di Renzo C, Tabrizian P, Kozuch DE, Fiel MI, Schwartz ME. Abdominal tuberculosis mimicking cancer clinically and on fluorodeoxyglucose (FDG)-positron emission tomography (PET) imaging: a two-case series. Am J Case Rep. 2020;21:e918901.
3
Liao F, Huang Z, Xu R, Luo Z, Qi W, Fan B, Yu J. Analysis of misdiagnosis and 18F-FDG PET/CT findings of lymph node tuberculosis. J Xray Sci Technol. 2022;30:941-951.
4
Yu WY, Lu PX, Assadi M, Huang XL, Skrahin A, Rosenthal A, Gabrielian A, Tartakovsky M, Wáng YXJ. Updates on 18 F-FDG-PET/CT as a clinical tool for tuberculosis evaluation and therapeutic monitoring. Quant Imaging Med Surg. 2019;9:1132-1146.
5
Sathekge M, Maes A, D’Asseler Y, Vorster M, Gongxeka H, Van de Wiele C. Tuberculous lymphadenitis: FDG PET and CT findings in responsive and nonresponsive disease. Eur J Nucl Med Mol Imaging. 2012;39:1184-1190.
